Vulnerabilities in the tumor and microenvironment in follicular lymphoma
- PMID: 34105816
- DOI: 10.1002/hon.2855
Vulnerabilities in the tumor and microenvironment in follicular lymphoma
Abstract
Follicular lymphoma (FL) is a paradigm of tumors that require the interaction between tumor and microenvironment cells to foster their development from initial steps to progression. Recent large-scale genome studies have uncovered multiple genetic alterations of FL that influence the microenvironment in two main directions, promoting tumor cell survival and proliferation and facilitating their evasion from immune antitumor signals. Understanding the crosstalk between tumor B-cells and the microenvironment will facilitate the identification of vulnerabilities that may offer novel targets for treatment of the patients. This review highlights recent findings showing the effect of common genetic mutations modulating the cell composition of the tumor microenvironment and the novel therapeutic perspectives to target these interactions.
Keywords: follicular lymphoma; genomic alterations; microenvironment; target therapies.
© 2021 John Wiley & Sons Ltd.
Similar articles
-
The yin and the yang of follicular lymphoma cell niches: role of microenvironment heterogeneity and plasticity.Semin Cancer Biol. 2014 Feb;24:23-32. doi: 10.1016/j.semcancer.2013.08.001. Epub 2013 Aug 23. Semin Cancer Biol. 2014. PMID: 23978491 Review.
-
The tumor microenvironment in follicular lymphoma.Clin Adv Hematol Oncol. 2012 Dec;10(12):810-8. Clin Adv Hematol Oncol. 2012. PMID: 23271353 Review.
-
Recent advances in understanding the biology of follicular lymphoma.Int J Hematol. 2025 Mar;121(3):326-330. doi: 10.1007/s12185-024-03764-6. Epub 2024 Mar 27. Int J Hematol. 2025. PMID: 38536645 Review.
-
The microenvironment in follicular lymphoma.Best Pract Res Clin Haematol. 2011 Jun;24(2):135-46. doi: 10.1016/j.beha.2011.02.007. Epub 2011 May 17. Best Pract Res Clin Haematol. 2011. PMID: 21658614 Review.
-
Impact of B cell/lymphoid stromal cell crosstalk in B-cell physiology and malignancy.Immunol Lett. 2019 Nov;215:12-18. doi: 10.1016/j.imlet.2019.02.005. Epub 2019 Mar 4. Immunol Lett. 2019. PMID: 30844420 Review.
Cited by
-
Impact of positive CD4 cells on event-free survival in follicular lymphoma patients.Cancer Med. 2024 Sep;13(17):e70117. doi: 10.1002/cam4.70117. Cancer Med. 2024. PMID: 39248131 Free PMC article.
-
Glucose metabolism in B cell malignancies: a focus on glycolysis branching pathways.Mol Oncol. 2024 Jul;18(7):1777-1794. doi: 10.1002/1878-0261.13570. Epub 2024 Jan 3. Mol Oncol. 2024. PMID: 38115544 Free PMC article. Review.
-
Unveiling the Role of the Tumor Microenvironment in the Treatment of Follicular Lymphoma.Cancers (Basel). 2022 Apr 26;14(9):2158. doi: 10.3390/cancers14092158. Cancers (Basel). 2022. PMID: 35565286 Free PMC article. Review.
-
The landscape of T-cell engagers for the treatment of follicular lymphoma.Oncoimmunology. 2024 Oct 8;13(1):2412869. doi: 10.1080/2162402X.2024.2412869. eCollection 2024. Oncoimmunology. 2024. PMID: 39398477 Free PMC article. Review.
References
REFERENCES
-
- Huet S , Sujobert P , Salles G . From genetics to the clinic: a translational perspective on follicular lymphoma. Nat Rev Cancer. 2018;18:224-239.
-
- Küppers R , Stevenson FK . Critical influences on the pathogenesis of follicular lymphoma. Blood. 2018;131:2297-2306. https://doi.org/10.1182/blood-2017-11-764365
-
- Kridel R , Sehn LH , Gascoyne RD . Pathogenesis of follicular lymphoma. J Clin Invest. 2012;122:3424-3431. https://doi.org/10.1172/JCI63186
-
- Schmidt J , Ramis-Zaldivar JE , Bonzheim I , et al. CREBBP gene mutations are frequently detected in in situ follicular neoplasia. Blood. 2018;132:2687-2690.
-
- Green MR . Chromatin modifying gene mutations in follicular lymphoma. Blood. 2018;131:595-604. https://doi.org/10.1182/blood-2017-08-737361
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources